Giulia Pellizzari
- Biomaterials top 10%
-
- Mast cells and histamine 3
- T-cell and B-cell Immunology 2
- Immune Cell Function and Interaction 2
-
- Monoclonal and Polyclonal Antibodies Research 4
-
- Chronic Lymphocytic Leukemia Research 3
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 1
-
- Chemotherapy-induced organ toxicity mitigation 1
-
- Food Allergy and Anaphylaxis Research 1
- Co-authors
- Debra H. JosephsJames SpicerHeather J. BaxSophia N. KaragiannisKristina M. IlievaAnthony CheungMariangela FiginiSilvana Canevari
- Cited by
- BiomaterialsImmunologyOncology
- Partner nations
- United KingdomItalyAustria
In The Last Decade
Giulia Pellizzari
11 papers receiving 562 citations
Hit Papers
Peers
Comparison fields: 5 of 75
- Biomaterials 105
- Immunology 143
- Oncology 160
- Molecular Biology 253
- Reproductive Medicine 31
Countries citing papers authored by Giulia Pellizzari
This map shows the geographic impact of Giulia Pellizzari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Pellizzari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Pellizzari more than expected).
Fields of papers citing papers by Giulia Pellizzari
This network shows the impact of papers produced by Giulia Pellizzari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Pellizzari. The network helps show where Giulia Pellizzari may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Giulia Pellizzari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 31 | |
| 2 | 2020 | 19 | |
| 3 | 2019 | 15 | |
| 4 | 2019 | 49 | |
| 5 | 2017 | 73 | |
| 6 | 2016 | 15 | |
| 7 | Targeting folate receptor alpha for cancer treatmentbreakdown → | 2016 | 348 |
| 8 | 2015 | 12 | |
| 9 | The clinical significance of the antiplatelet antibody test based on results for 265 thrombocytopenic patients. | 1994 | 0 |
| 10 | Single step immunophenotyping of acute leukemias not classifiable by standard morphology and cytochemistry: a practical approach. | 1994 | 1 |
| 11 | [Comparative clinical study of a new imidazole molecule (fluconazole) and ketaconazole in the treatment of Candida albicans vulvovaginitis]. | 1992 | 2 |
| 12 | The effect of thymic substances on T circulating cells of patients treated for Hodgkin's disease. | 1989 | 5 |
About Giulia Pellizzari
Giulia Pellizzari is a scholar working on Genetics, Immunology, Hematology, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine, having authored 12 papers that have together received 570 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (4 papers), Mast cells and histamine (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), T-cell and B-cell Immunology (2 papers), Immune Cell Function and Interaction (2 papers), Chemotherapy-induced organ toxicity mitigation (1 paper), Food Allergy and Anaphylaxis Research (1 paper) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper). The work is most often cited by research in Biomaterials (105 citations), Immunology (143 citations), Oncology (160 citations), Molecular Biology (253 citations) and Reproductive Medicine (31 citations). Giulia Pellizzari has collaborated with scholars based in United Kingdom, Italy and Austria. Frequent co-authors include Debra H. Josephs, James Spicer, Heather J. Bax, Sophia N. Karagiannis, Kristina M. Ilieva, Anthony Cheung, Mariangela Figini, Silvana Canevari, Andrew Tutt and James W. Opzoomer. Their work appears in journals such as mAbs, Oncotarget, Chemical Research in Toxicology, Cells and Trends in Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.